MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.companySEC Filings & Insider Trading Activity 2026
Latest MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on November 7, 2025, an 8-K current report filed on February 25, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) (SEC CIK 1823239), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year fiscal 2025 earnings released Feb 25, 2026 — full results in Exhibit 99.1
- • Reporting period covers quarter and full year ended December 31, 2025
Recent 8-K FilingsCurrent Reports
AI-powered analysis of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | — | $288.9M | $259.2M | $185.7M |
| Gross Profit | — | $140.2M | $108.3M | $34.0M |
| Operating Income | — | -$31.6M | -$235.6M | -$215.3M |
| Net Income | $220.2M | -$119.0M | -$144.8M | -$130.8M |
| Gross Margin | — | 48.5% | 41.8% | 18.3% |
| Op. Margin | — | -11.0% | -90.9% | -115.9% |
| Net Margin | — | -41.2% | -55.9% | -70.4% |
| Balance Sheet | ||||
| Total Assets | $2.3B | $1.5B | $1.0B | $770.6M |
| Equity | — | $416.8M | $325.3M | $212.4M |
| ROE | — | -28.6% | -44.5% | -61.6% |
Source: XBRL financial data from MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
10-K | Feb 26, 2026 | Dec 31, 2025 | — | |
8-K | Feb 25, 2026 | — | Analysis | — |
10-Q | Nov 7, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 11, 2025 | Jun 30, 2025 | — | |
10-Q | May 12, 2025 | Mar 31, 2025 | — | |
10-K | Mar 18, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | — | |
10-Q | May 9, 2024 | Mar 31, 2024 | — | |
10-K | Feb 29, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Feb 28, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 4, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 5, 2022 | Jun 30, 2022 | — | |
10-Q | May 6, 2022 | Mar 31, 2022 | — | |
10-K | Mar 1, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 15, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 11, 2021 | Jun 30, 2021 | — | |
10-Q | May 12, 2021 | Mar 31, 2021 | — | |
10-K | Mar 22, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest MRVI SEC filings in 2026?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 7, 2025, an 8-K current report on February 25, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did MRVI file its most recent 10-K annual report?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view MRVI 10-Q quarterly reports?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)'s most recent 10-Q quarterly report was filed on November 7, 2025. SignalX displays every MRVI 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has MRVI filed recently?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)'s most recent 8-K was filed on February 25, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find MRVI insider trading activity (Form 4)?
SignalX aggregates every MRVI Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does MRVI file with the SEC?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new MRVI filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).
What is MRVI's SEC CIK number?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)'s SEC CIK (Central Index Key) number is 1823239. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1823239 to look up all MRVI filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find MRVI return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of MARAVAI LIFESCIENCES HOLDINGS, INC. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 22+ filings.